Controllable genetic manipulation of apoptosis of cells in culture

Cytotechnology

Volumn 22, Issue 1-3, 1996, Pages 157-167

  Littlewood, Trevor ^a   McCarthy, Nicola ^a   Whyte, Moira ^a   Pelengaris, Stella ^a   James, Claerwen ^a   Evan, Gerard ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

apoptosis; cysteine protease; Myc; p53; regulation

Indexed keywords

MAMMALIA;

EID: 0030432004     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00353935     Document Type: Conference Paper

References (43)

1. Amati B, Dalton S, Brooks M, Littlewood T, Evan G and Land H (1992) Transcriptional activation by c-Myc oncoprotein in yeast requires interaction with Max. Nature 359: 423-426.
2. Amati B, Brooks M, Levy N, Littlewood T, Evan G and Land H (1993a) Oncogenic activity of the c-Myc protein requires dimerisation with Max. Cell 72: 233-245.
3. Amati B, Littlewood T, Evan G and Land H (1993b) The c-Myc protein induces cell cycle progression and apoptosis through dimerisation with Max. EMBO J 12: 5083-5087.
4. Askew D, Ashmun R, Simmons B and Cleveland J (1991) Constitutive c-myc expression in IL-3-dependent myeloid cell line suppresses cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922.
5. Berberich S, Hyde-DeRuyscher N, Espenshade P and Cole M (1992) max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors. Oncogene 7: 775-779.
6. Bissonnette R, Echeverri F, Mahboubi A and Green D (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552-554.
7. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN and Weintraub H (1990) Sequence-specific DNA binding by the c-Myc protein. Science 250: 1149-1151.
8. Blackwood EM and Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211-1217.
9. Blackwood EM, Luscher B and Eisenman RN (1992) Myc and Max associate in vivo. Genes Dev 6: 71-80.
10. Braselmann S, Graninger P and Busslinger M (1993) A selective transcriptional induction system for mammalian cells based on Ga14-estrogen receptor fusion proteins. Proc Natl Acad Sci USA 90: 1657-1661.
11. Cohen J (1993) Overview: Mechanisms of apoptosis. Immunol Today 14: 126-130.
12. DePinho RA, Schreiber-Agus N and Alt FW (1991) myc family oncogenes in the development of normal and neoplastic cells. Adv Canc Res 57: 1-46.
13. Eilers M, Picard D, Yamamoto KR and Bishop MJ (1989) Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340: 66-68.
14. Eilers M, Schirm S and Bishop JM (1991) The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J 10: 133-141.
15. Enari M, Hug H and Nagata S (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-81.
16. Evan G and Littlewood T (1993) The role of c-myc in cell growth. Curr Opin Genet and Dev. 3: 44-49.
17. Evan G, Wyllie A, Gilbert C, Littlewood T, Land H, Brooks M, Waters C, Penn L and Hancock D (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 63: 119-125.
18. Fanidi A, Harrington E and Evan G (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554-556.
19. Fletcher DS, Agarwal L, Chapman KT, Chin J, Egger LA, Limjuco G, Luell S, MacIntyre DE, EP, Thornberry NA et al. (1995) A synthetic inhibitor of interleukin-1 beta converting enzyme prevents endotoxin-induced interleukin-1 beta production in vitro and in vivo. J Interferon Cytokine Res 15: 243-248.
20. Freytag SO (1988) Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell. Biol. 8: 1614-1624.
21. Gerschenson LE and Rotello RJ (1992) Apoptosis: a different type of cell death. FASEB J 6: 2450-2455.
22. Harrington E, Fanidi A, Bennett M and Evan G (1994) Modulation of Myc-induced apoptosis by specific cytokines. EMBO J 13: 3286-3295.
23. Hermeking H and Eick D (1994) Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091-2093.
24. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336.
25. Kato GJ, Barrett J, Villa GM and Dang CV (1990) An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol 10: 5914-5920.
26. Land H, Parada LF and Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596-602.
27. Littlewood T, Amati B, Land H and Evan G (1992) Max and c-Myc/Max DNA binding activities in cell extracts. Oncogene 7: 1783-1792.
28. Littlewood T, Hancock D, Danielian P, Parker M and Evan G (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nuc Acids Res 23: 1686-1690.
29. Los M, Van dCM, Penning LC Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W and Schulze OK (1995) Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375: 81-83.
30. Mattioni T, Louvion JF and Picard D (1994) Regulation of protein activities by fusion to steroid-binding domains. Methods Cell Biol. 43: 335-352.
31. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
32. Penn L, Brooks M, Laufer E, Littlewood T, Morgenstern J, Evan G, Lee W and Land H (1990) Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol Cell Biol 10: 4961-4966.
33. Prendergast GC, Lawe D and Ziff EB (1991) Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65: 395-407.
34. Sakamuro D, Eviner V, Elliot KJ, Showe L, White E and Prendergast GC (1995) c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11: 2411-2418.
35. Shaulian E, Zeuberman A, Ginsberg D and Oren M (1992) Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol 12: 5581-5592.
36. Stone J, de Lange T, Ramsay G, Jakobvits E, Bishop JM, Varmus H and Lee W (1987) Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7: 1697-1709.
37. Strasser A, Harris AW, Bath ML and Cory S (1990) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331-333.
38. Vaux DL, Cory S and Adams KM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
39. Wagner A, Kokontis J and Hay N (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell-cycle arrest and the ability of p53 to induce p21(waf1/cip1). Genes and Dev 8: 2871-2830.
40. Wagner A, Le Beau M, Diaz M and Hay N (1992) Expression, regulation and chromosomal localization of the Max gene. Proc Natl Acad Sci USA 89: 3111-3115.
41. Wagner AJ, Small MB and Hay N (1993) Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol cell Biol 13: 2432-2440.
42. Walker NI, Harmon BV, Gobe GC and Kerr JF (1988) Patterns of cell death. Methods Achiev Exp Pathol 13: 18-54.
43. Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E and Spandidos DA (1987) Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br J Cancer 56: 251-259.